News Glenmark Launches Cost-Effective Diabetes and Weight Loss Injectable Drug in India Glenmark's Lirafit presents a cost-effective option for diabetes management, but its daily injection requirement might hinder its success against weekly injectable drugs like Dulaglutide.
News Take Charge @18 - Fighting Hypertension Ignorance in India Glenmark & OMRON team up for "Take Charge @18" to combat hypertension in India by raising awareness about blood pressure screening from age 18.
